Samsung recently confirmed that it will be making its exit in the auto business. The company was said to have made the decision to end its 26-year venture with Renault.
The announcement about its departure from this line of business came just a few days after Samsung’s vice chairman and heir, Lee Jae Yong, was granted parole and regained his freedom after months of imprisonment.
According to The Korea Times, it was revealed on Thursday, Aug. 19, through a regulatory filing to the Korea Exchange, that Samsung Card, Samsung Group's card issuance subsidiary, is poised to sell all the stake it owns in Renault Samsung Motors.
"Samsung Card is in the process of selling the company-owned 19.9% stake in Renault Samsung Motor,” part of the statement in the filing reads. “But other specifics such as the type of stake sale and form of due process have yet to be decided."
Then again, it was reported that Samsung Card’s plan to sell its stake may not be easy because Renault Samsung is not financially sound as of this moment. It was added that its corporate sustainability is not in good shape as well, so the sale may encounter many hurdles.
In fact, the auto company was said to have lost around ₩79.6 billion in operating costs last year. It turned out that this was the firm’s first loss in the last eight years.
There are people who are saying that Samsung Card is withdrawing from its venture with Renault due to today’s rapid transition to electric vehicles, but this could not be confirmed. At any rate, a source said that Samsung Card will not be selling its stake at a high price.
The company already sent out invitations for bids to private equity funds (PEFs) and other local and foreign financial investors.
Meanwhile, The Korea Economic Daily reported that Samsung Card’s stake sale was already expected due to Renault Samsung’s poor performance that leads to low earnings. On top of this, it was pointed out that the auto firm has a strained relationship with its own labor union. These internal company issues were said to have been negatively affecting its sales in South Korea and overseas, and the decline is continuing.


Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
Henkel in Advanced Talks to Acquire Olaplex at $2 Per Share
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Gold Prices Surge on U.S.-Iran Ceasefire Reports
Australia's Inflation Eases in February but Core Pressures Persist
U.S. Stocks Tumble as Iran Peace Deal Uncertainty Spooks Markets
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
U.S. Oil Prices Slide as Middle East Ceasefire Talks Spark Market Optimism
Global Flight Cancellations 2026: Middle East Air Travel Chaos Explained
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
Bank of Japan Unveils New Inflation Gauge to Support Case for Future Rate Hikes
China Opens Door to Stronger U.S. Trade Ties Amid Rising Tensions 



